Legend Biotech is a publicly traded company trading on NASDAQ, led by CEO Ying Huang.
Upcoming earnings announcement for Legend Biotech
Past 12 earnings reports for Legend Biotech
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | $0.01Est: -$0.18 | +105.6% | $306.3MEst: $306.0M | +0.1% | — |
| Nov 12, 2025 | Q3 2025 | -$0.05Est: -$0.12 | +58.3% | $272.3MEst: $276.0M | -1.3% | — |
| Aug 11, 2025 | Q2 2025 | -$0.34Est: -$0.21 | -61.9% | $255.1MEst: $227.6M | +12.1% | — |
| May 13, 2025 | Q1 2025 | -$0.07Est: -$0.25 | +72.0% | $195.1MEst: $193.9M | +0.6% | — |
| Mar 11, 2025 | Q4 2024 | -$0.15Est: -$0.33 | +54.5% | $186.5MEst: $178.9M | +4.2% | — |
| Nov 12, 2024 | Q3 2024 | -$0.34Est: -$0.42 | +19.0% | $160.2MEst: $143.9M | +11.4% | — |
| Aug 9, 2024 | Q2 2024 | -$0.05Est: -$0.38 | +86.8% | $186.5MEst: $126.6M | +47.3% | — |
| May 13, 2024 | Q1 2024 | -$0.16Est: -$0.34 | +52.9% | $94.0MEst: $152.6M | -38.4% | — |
| Mar 11, 2024 | Q4 2023 | -$0.40Est: -$0.83 | +51.8% | $79.5MEst: $86.4M | -8.0% | — |
| Nov 20, 2023 | Q3 2023 | -$0.17Est: -$0.65 | +73.8% | $96.0MEst: $97.3M | -1.3% | — |
| Aug 15, 2023 | Q2 2023 | -$0.57Est: -$0.69 | +17.4% | $73.3MEst: $53.2M | +37.8% | — |
| May 18, 2023 | Q1 2023 | -$0.34 | — | $36.3M | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.